Ravi Ranatunga.R
About Ravi Ranatunga.R
Ravi Ranatunga is the Director of Corporate R&D - Global Analytical at Procter & Gamble, with extensive experience in analytical chemistry and a focus on innovation productivity and organizational culture.
Title
Ravi Ranatunga.R holds the position of Director, Corporate R&D - Global Analytical at Procter & Gamble.
Achievements at Procter & Gamble
Ravi Ranatunga.R has been with Procter & Gamble since 1998, initially working as a Scientist/Senior Scientist for nine years. In 2007, he advanced to the role of Director, Corporate R&D - Global Analytical. His focus includes innovation productivity through automation and work process improvements and plays an important role in implementing strategies for global capital acquisition. He also emphasizes organizational culture development, focusing on Diversity & Inclusion, Quality, and Safety.
Previous Experience
Before joining Procter & Gamble, Ravi Ranatunga.R was a Visiting Scientist at the University of Minnesota from 1996 to 1998. He also held the position of Senior Lecturer (Associate Professor) at the University of Peradeniya in Sri Lanka from 1993 to 1996. Additionally, he worked as an Associate Research Chemist at Shell Oil Company from 1990 to 1992.
Education and Expertise
Ravi Ranatunga.R holds a Postdoctoral degree in Analytical Chemistry from the University of Minnesota, where he studied from 1996 to 1998. Prior to that, he achieved a PhD in Analytical Chemistry from the University of Houston, studying from 1985 to 1989. His academic background has equipped him with expertise in global capital acquisition strategy and management, with a focus on innovation productivity.
Professional Focus Areas
In his role at Procter & Gamble, Ravi Ranatunga.R emphasizes several key focus areas: he drives innovation productivity through automation and work process improvements, while also fostering a strong organizational culture. His key initiatives in this regard include ensuring Diversity & Inclusion, maintaining high standards of Quality, and prioritizing Safety across the company's operations globally.